Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 2, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
5
Recruiting, any sponsor type, condition "restless legs"
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed100
5 trials
Showing 1 to 5, recently updated first.
Salem Anaesthesia Pain ClinicAcademic, hospital or other
NCT05618002 · 250 participants (planned) · Start Jan 2, 2023 · Primary completion Jun 28, 2027
Drug: Lemborexant · For: Chronic Insomnia; Chronic Pain; Restless Leg Syndrome (RLS) and 6 more
Sites: Surrey, Canada
Sunnybrook Health Sciences CentreAcademic, hospital or other
NCT06863740 · 30 participants (planned) · Start Jul 25, 2025 · Primary completion Dec 2026
Drug: Cannabis oil; Cannabis placebo · For: Restless Leg Syndrome (RLS)
Sites: Toronto, Canada · 2 sites in all
- A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With DipyridamolePivotal-lookingRecruiting
Yunfeng XiaAcademic, hospital or other
NCT07199504 · 80 participants (planned) · Start Sep 20, 2025 · Primary completion Dec 31, 2026
Drug: Dipyridamole 50mg tid · For: Restless Leg Syndrome Due to Uraemia
Sites: Chongqing, China
Beijing Friendship HospitalAcademic, hospital or other
NCT07453862 · 20 participants (planned) · Start Mar 10, 2026 · Primary completion Jun 30, 2027
Drug: Crisugabalin · For: Restless Leg Syndrome (RLS); Variant Restless Legs Syndrome
Sites: Beijing, China
- Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's DiseasePivotal-lookingRecruiting
University of Texas at AustinAcademic, hospital or other
NCT03082755 · 156 participants (planned) · Start Jul 1, 2017 · Primary completion Aug 31, 2022
Drug: Gabapentin Enacarbil; Placebo Oral Tablet · For: Alzheimer Disease
Sites: Austin, Texas
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.